These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2993022)

  • 1. Vasoactive intestinal peptide receptor activity and specificity during enterocyte-like differentiation and retrodifferentiation of the human colonic cancerous subclone HT29-18.
    Chastre E; Emami S; Rosselin G; Gespach C
    FEBS Lett; 1985 Sep; 188(2):197-204. PubMed ID: 2993022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VIP receptor activity during HT29-18 cell differentiation and rat intestinal development.
    Chastre E; Emami S; Gespach C
    Peptides; 1986; 7 Suppl 1():113-9. PubMed ID: 3018689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal peptide receptor regulation and reversible desensitization in human colonic carcinoma cells in culture.
    Boissard C; Marie JC; Hejblum G; Gespach C; Rosselin G
    Cancer Res; 1986 Sep; 46(9):4406-13. PubMed ID: 3015387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of GRF with VIP receptors and stimulation of adenylate cyclase in rat and human intestinal epithelial membranes. Comparison with PHI and secretin.
    Laburthe M; Amiranoff B; Boige N; Rouyer-Fessard C; Tatemoto K; Moroder L
    FEBS Lett; 1983 Aug; 159(1-2):89-92. PubMed ID: 6307754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal peptide receptor activity in human fetal enterocytes.
    Gespach C; Chastre E; Emami S; Mulliez N
    FEBS Lett; 1985 Jan; 180(2):196-202. PubMed ID: 2981718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fragment of vasoactive intestinal peptide, VIP(10-28), is an antagonist of VIP in the colon carcinoma cell line, HT29.
    Turner JT; Jones SB; Bylund DB
    Peptides; 1986; 7(5):849-54. PubMed ID: 3025826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine and VIP interactions with receptor-cyclic AMP systems in the human gastric cancer cell line HGT-1.
    Emami S; Gespach C; Forgue-Lafitte ME; Broer Y; Rosselin G
    Life Sci; 1983 Aug; 33(5):415-23. PubMed ID: 6192308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Desensitization to VIP by down regulation of its peptide receptors in transformed HT-29 cells of human colonic epithelium in culture].
    Boissard C; Hejblum G; Marie JC; Gespach C; Rosselin G
    C R Acad Sci III; 1984; 299(19):795-8. PubMed ID: 6099208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phorbol ester induces loss of VIP stimulation of adenylate cyclase and VIP-binding sites in HT29 cells.
    Bozou JC; Couvineau A; Rouyer-Fessard C; Laburthe M; Vincent JP; Kitabgi P
    FEBS Lett; 1987 Jan; 211(2):151-4. PubMed ID: 3026847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the VIP- and secretin-stimulated adenylate cyclase system from human lung.
    Taton G; Delhaye M; Camus JC; de Neef P; Chatelain P; Robberecht P; Christophe J
    Pflugers Arch; 1981 Sep; 391(3):178-82. PubMed ID: 6126856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forskolin stimulates adenylate cyclase in human colonic crypts: interaction with VIP.
    Boige N; Amiranoff B; Munck A; Laburthe M
    Eur J Pharmacol; 1984 May; 101(1-2):111-7. PubMed ID: 6540196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
    Gespach C; Bawab W; de Cremoux P; Calvo F
    Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the cAMP-generating system by vasoactive intestinal polypeptide (VIP) in the human laryngeal malignant cell line HEp-2.
    Prost A; Emami S; Rosselin G; Gespach C
    Biosci Rep; 1984 Dec; 4(12):1045-50. PubMed ID: 6085015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
    Couvineau A; Rousset M; Laburthe M
    Biochem J; 1985 Oct; 231(1):139-43. PubMed ID: 2998337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional receptors for VIP, GIP, glucagon-29 and -37 in the HGT-1 human gastric cancer cell line.
    Emami S; Chastre E; Bodéré H; Gespach C; Bataille D; Rosselin G
    Peptides; 1986; 7 Suppl 1():121-7. PubMed ID: 3018690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal peptide receptor antagonist [4Cl-D-Phe6, Leu17] VIP.
    Pandol SJ; Dharmsathaphorn K; Schoeffield MS; Vale W; Rivier J
    Am J Physiol; 1986 Apr; 250(4 Pt 1):G553-7. PubMed ID: 2421587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural requirements for VIP interaction with specific receptors in human and rat intestinal membranes: effect of nine partial sequences.
    Couvineau A; Rouyer-Fessard C; Fournier A; St Pierre S; Pipkorn R; Laburthe M
    Biochem Biophys Res Commun; 1984 Jun; 121(2):493-8. PubMed ID: 6329205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do secretin and vasoactive intestinal peptide have independent receptors on striatal neurons and glial cells in primary cultures?
    Chneiweiss H; Glowinski J; Premont J
    J Neurochem; 1986 Aug; 47(2):608-13. PubMed ID: 3016177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric inhibitory peptide (GIP), pancreatic glucagon and vasoactive intestinal peptide (VIP) are cAMP-inducing hormones in the human gastric cancer cell line HGT-1. Homologous desensitization of VIP receptor activity.
    Gespach C; Emami S; Rosselin G
    Biochem Biophys Res Commun; 1984 Apr; 120(2):641-9. PubMed ID: 6329177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of vasoactive intestinal peptide-mediated protein phosphorylation in human lymphoblasts and colonic epithelial cells.
    O'Dorisio MS; Campolito LB
    Mol Immunol; 1989 Jun; 26(6):583-90. PubMed ID: 2770750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.